T1	PROC 46 124	Estudio de mantenimiento y extensión a largo plazo, de la eficacia y seguridad
T2	DISO 166 185	enfermedad de Crohn
#1	AnnotatorNotes T2	C0010346; Crohn Disease; Disease or Syndrome
T3	CHEM 128 140	Upadacitinib
T4	PROC 255 373	Estudio multicéntrico aleatorizado, doble ciego y controlado con placebo de mantenimiento y de extensión a largo plazo
T5	CHEM 432 439	ABT-494
#2	AnnotatorNotes T5	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T6	PROC 380 414	evaluar la eficacia y la seguridad
#3	AnnotatorNotes T6	C0511730; Identify product efficacy and safety issues; Health Care Activity
T7	DISO 456 475	enfermedad de Crohn
#4	AnnotatorNotes T7	C0010346; Crohn Disease; Disease or Syndrome
T8	CHEM 418 430	upadacitinib
T9	PROC 624 647	tratamiento doble ciego
T10	PROC 749 763	procedimientos
#5	AnnotatorNotes T10	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T11	CHEM 930 942	upadacitinib
T12	PROC 1026 1040	procedimientos
#6	AnnotatorNotes T12	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T13	CHEM 1338 1350	upadacitinib
T14	DISO 1309 1326	hipersensibilidad
#7	AnnotatorNotes T14	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T15	CHEM 1357 1368	excipientes
#8	AnnotatorNotes T15	C0015237; Pharmaceutical Excipient; Biomedical or Dental Material
T16	DISO 1384 1398	evento adverso
#9	AnnotatorNotes T16	C0877248; Adverse event; Pathologic Function
T17	DISO 1572 1581	infección
#10	AnnotatorNotes T17	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T18	DISO 1735 1746	infecciones
#11	AnnotatorNotes T18	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T19	PROC 1773 1784	tratamiento
#12	AnnotatorNotes T19	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T20	PROC 1835 1846	tratamiento
#13	AnnotatorNotes T20	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T21	DISO 1853 1862	infección
#14	AnnotatorNotes T21	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T22	DISO 1887 1896	infección
#15	AnnotatorNotes T22	C0009450; Communicable Diseases; Disease or Syndrome | C3714514; Infection; Pathologic Function
T23	PROC 1919 1929	evaluación
#16	AnnotatorNotes T23	C1261322; Evaluation procedure; Health Care Activity
T24	DISO 1968 1977	displasia
#17	AnnotatorNotes T24	C0334044; Dysplasia; Pathologic Function
T25	ANAT 1991 1999	colónica
#18	AnnotatorNotes T25	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T26	PROC 2014 2027	diagnosticada
#19	AnnotatorNotes T26	C0011900; Diagnosis; Diagnostic Procedure
T27	PROC 2034 2044	endoscopia
#20	AnnotatorNotes T27	C0014245; Endoscopy (procedure); Diagnostic Procedure
T28	DISO 1980 1999	malignidad colónica
T29	CHEM 142 149	ABT-494
#21	AnnotatorNotes T29	C4308782; ABT-494; Organic Chemical · Pharmacologic Substance
T30	PROC 1812 1821	medicarse
#22	AnnotatorNotes T30	C3469597; Administration of medication; Therapeutic or Preventive Procedure
T31	Date 13 17	2017
T32	Date 83 96	a largo plazo
T33	LIVB 154 161	sujetos
#23	AnnotatorNotes T33	C0681850; Study Subject; Group
T34	Date 360 373	a largo plazo
T35	LIVB 444 451	sujetos
#24	AnnotatorNotes T35	C0681850; Study Subject; Group
T36	Date 779 791	la semana 12
T37	Date 794 806	la semana 24
T38	LIVB 1263 1275	investigador
#25	AnnotatorNotes T38	C0035173; Research Personnel; Professional or Occupational Group
T39	LIVB 1479 1491	investigador
#26	AnnotatorNotes T39	C0035173; Research Personnel; Professional or Occupational Group
T40	LIVB 1505 1511	sujeto
#27	AnnotatorNotes T40	C0681850; Study Subject; Group
T42	Duration 1602 1609	crónica
#28	AnnotatorNotes T42	C0205191; chronic; Temporal Concept
T43	LIVB 1637 1649	investigador
#29	AnnotatorNotes T43	C0035173; Research Personnel; Professional or Occupational Group
T44	LIVB 1667 1673	sujeto
#30	AnnotatorNotes T44	C0681850; Study Subject; Group
T45	LIVB 1723 1730	sujetos
#31	AnnotatorNotes T45	C0681850; Study Subject; Group
T46	Date 1747 1755	en curso
T48	Neg_cue 1809 1811	NO
T49	LIVB 1934 1946	investigador
#32	AnnotatorNotes T49	C0035173; Research Personnel; Professional or Occupational Group
T41	Date 2095 2104	Semana 24
T47	Date 2150 2159	Semana 40
T50	LIVB 600 612	Participante
#33	AnnotatorNotes T50	C4554048; Study Participant; Population Group
T51	LIVB 719 731	Participante
#34	AnnotatorNotes T51	C4554048; Study Participant; Population Group
T52	LIVB 831 843	Participante
#35	AnnotatorNotes T52	C4554048; Study Participant; Population Group
T53	LIVB 875 887	Participante
#36	AnnotatorNotes T53	C4554048; Study Participant; Population Group
T54	LIVB 996 1008	Participante
#37	AnnotatorNotes T54	C4554048; Study Participant; Population Group
T55	LIVB 1154 1166	Participante
#38	AnnotatorNotes T55	C4554048; Study Participant; Population Group
T56	LIVB 1279 1291	Participante
#39	AnnotatorNotes T56	C4554048; Study Participant; Population Group
T57	LIVB 1545 1557	Participante
#40	AnnotatorNotes T57	C4554048; Study Participant; Population Group
T58	LIVB 1950 1963	Participantes
#41	AnnotatorNotes T58	C4554048; Study Participant; Population Group
T59	Quantifier_or_Qualifier 2068 2073	final
T60	PROC 2061 2067	visita
#43	AnnotatorNotes T60	C1512346; Patient Visit; Health Care Activity
A1	Assertion T30 Negated
A2	Status T14 History_of
A3	Status T16 History_of
#44	AnnotatorNotes T32	C0443252; Long-term; Temporal Concept
#45	AnnotatorNotes T34	C0443252; Long-term; Temporal Concept
#46	AnnotatorNotes T9	C0013072; Double-Blind Method; Research Activity
#47	AnnotatorNotes T3	C4726929; upadacitinib; Organic Chemical · Pharmacologic Substance
#48	AnnotatorNotes T8	C4726929; upadacitinib; Organic Chemical · Pharmacologic Substance
#49	AnnotatorNotes T11	C4726929; upadacitinib; Organic Chemical · Pharmacologic Substance
#50	AnnotatorNotes T13	C4726929; upadacitinib; Organic Chemical · Pharmacologic Substance
#51	AnnotatorNotes T28	C0009375; Colonic Neoplasms; Neoplastic Process
T61	Observation 1519 1541	apto para este estudio
A4	Assertion T61 Negated
#42	AnnotatorNotes T61	C3242266; patient not eligible; Finding
T62	Neg_cue 1512 1514	no
R1	Negation Arg1:T62 Arg2:T61	
R2	Negation Arg1:T48 Arg2:T30	
R3	Overlap Arg1:T1 Arg2:T32	
R4	Experiences Arg1:T33 Arg2:T3	
R5	Experiences Arg1:T33 Arg2:T29	
R6	Experiences Arg1:T33 Arg2:T2	
T63	Observation 190 214	completaron los estudios
A5	Status T63 History_of
#52	AnnotatorNotes T63	C2732579; Completion of clinical trial; Finding
T64	Observation 484 507	finalizado los estudios
A6	Status T64 History_of
#53	AnnotatorNotes T64	C2732579; Completion of clinical trial; Finding
R7	Experiences Arg1:T35 Arg2:T8	
R8	Experiences Arg1:T35 Arg2:T5	
R9	Experiences Arg1:T35 Arg2:T7	
R10	Overlap Arg1:T4 Arg2:T34	
R11	Before Arg1:T63 Arg2:T1	
R12	Before Arg1:T64 Arg2:T4	
R13	Experiences Arg1:T50 Arg2:T9	
R14	Overlap Arg1:T10 Arg2:T36	
R15	Overlap Arg1:T10 Arg2:T37	
R16	Experiences Arg1:T51 Arg2:T10	
T65	Observation 736 763	completa los procedimientos
T66	PROC 654 661	Estudio
#54	AnnotatorNotes T66	C0008976; Clinical Trials; Research Activity
A7	Status T66 History_of
T67	PROC 672 679	Estudio
A8	Status T67 History_of
#55	AnnotatorNotes T67	C0008976; Clinical Trials; Research Activity
R17	Overlap Arg1:T9 Arg2:T66	
R18	Overlap Arg1:T9 Arg2:T67	
T68	PROC 499 507	estudios
A9	Status T68 History_of
#56	AnnotatorNotes T68	C0008976; Clinical Trials; Research Activity
T69	PROC 206 214	estudios
A10	Status T69 History_of
#57	AnnotatorNotes T69	C0008976; Clinical Trials; Research Activity
R19	Before Arg1:T68 Arg2:T4	
R20	Before Arg1:T69 Arg2:T1	
T70	PROC 949 956	Estudio
A11	Status T70 History_of
#58	AnnotatorNotes T70	C0008976; Clinical Trials; Research Activity
T71	Observation 1013 1040	completa los procedimientos
T72	Observation 698 715	respuesta clínica
#59	AnnotatorNotes T72	C4055223; Clinical Response; Finding
T73	Observation 975 992	respuesta clínica
#60	AnnotatorNotes T73	C4055223; Clinical Response; Finding
R21	Overlap Arg1:T9 Arg2:T72	
R22	Overlap Arg1:T67 Arg2:T72	
R23	Overlap Arg1:T66 Arg2:T72	
R24	Overlap Arg1:T70 Arg2:T73	
R25	Experiences Arg1:T53 Arg2:T11	
R26	Experiences Arg1:T53 Arg2:T73	
R27	Overlap Arg1:T11 Arg2:T73	
T74	Observation 1212 1232	candidato inadecuado
#61	AnnotatorNotes T74	C3242266; patient not eligible; Finding
R28	Has_Quantifier_or_Qualifier Arg1:T55 Arg2:T74	
R29	Experiences Arg1:T56 Arg2:T14	
R30	Causes Arg1:T13 Arg2:T14	
R31	Causes Arg1:T15 Arg2:T14	
R32	Experiences Arg1:T56 Arg2:T16	
R33	Has_Quantifier_or_Qualifier Arg1:T56 Arg2:T61	
R34	Has_Quantifier_or_Qualifier Arg1:T40 Arg2:T61	
R35	Experiences Arg1:T40 Arg2:T14	
R36	Experiences Arg1:T40 Arg2:T16	
R37	Before Arg1:T16 Arg2:T61	
T75	PROC 1410 1417	Estudio
A12	Status T75 History_of
#62	AnnotatorNotes T75	C0008976; Clinical Trials; Research Activity
T76	PROC 1445 1452	Estudio
A13	Status T76 History_of
#63	AnnotatorNotes T76	C0008976; Clinical Trials; Research Activity
R38	Overlap Arg1:T16 Arg2:T75	
R39	Overlap Arg1:T16 Arg2:T76	
T77	PROC 1534 1541	estudio
#64	AnnotatorNotes T77	C0008976; Clinical Trials; Research Activity
R40	Before Arg1:T75 Arg2:T77	
R41	Before Arg1:T76 Arg2:T77	
R42	Before Arg1:T16 Arg2:T77	
R43	Has_Duration_or_Interval Arg1:T17 Arg2:T42	
R44	Experiences Arg1:T57 Arg2:T17	
T78	Observation 1582 1592	recurrente
#65	AnnotatorNotes T78	C0679254; Disease recurrence; Finding
R45	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T78	
T79	Quantifier_or_Qualifier 1593 1599	activa
#66	AnnotatorNotes T79	C0205177; Active; Qualitative Concept | C0679217; Active State; Idea or Concept
R46	Has_Quantifier_or_Qualifier Arg1:T17 Arg2:T79	
R47	Experiences Arg1:T44 Arg2:T17	
T80	Observation 1681 1701	candidato inadecuado
#67	AnnotatorNotes T80	C3242266; patient not eligible; Finding
R48	Has_Quantifier_or_Qualifier Arg1:T44 Arg2:T80	
R50	Before Arg1:T17 Arg2:T80	
R51	Experiences Arg1:T45 Arg2:T18	
R52	Overlap Arg1:T18 Arg2:T46	
R53	Experiences Arg1:T45 Arg2:T19	
R54	Experiences Arg1:T45 Arg2:T30	
R55	Before Arg1:T20 Arg2:T30	
T81	Observation 1835 1846;1871 1881	tratamiento completado
#68	AnnotatorNotes T81	C0580352; Treatment completed; Finding
R56	Before Arg1:T81 Arg2:T30	
R57	Experiences Arg1:T45 Arg2:T21	
T82	Observation 1902 1908	curada
#69	AnnotatorNotes T82	C0184780; Disease condition determination, cured; Finding
R58	Has_Quantifier_or_Qualifier Arg1:T22 Arg2:T82	
R59	Before Arg1:T82 Arg2:T30	
R60	Experiences Arg1:T45 Arg2:T22	
R61	Experiences Arg1:T58 Arg2:T24	
R62	Experiences Arg1:T58 Arg2:T28	
R63	Location_of Arg1:T25 Arg2:T28	
R64	Experiences Arg1:T58 Arg2:T27	
R65	Overlap Arg1:T27 Arg2:T60	
R66	Has_Quantifier_or_Qualifier Arg1:T60 Arg2:T59	
R67	Overlap Arg1:T60 Arg2:T41	
#70	AnnotatorNotes T59	C1517741; Last; Qualitative Concept
T83	PROC 2078 2085	Estudio
#71	AnnotatorNotes T83	C0008976; Clinical Trials; Research Activity
A14	Status T83 History_of
T84	PROC 2108 2115	Estudio
A15	Status T84 History_of
#72	AnnotatorNotes T84	C0008976; Clinical Trials; Research Activity
A16	Status T60 History_of
T85	PROC 2133 2140	Estudio
A17	Status T85 History_of
#73	AnnotatorNotes T85	C0008976; Clinical Trials; Research Activity
R71	Overlap Arg1:T60 Arg2:T47	
R72	Overlap Arg1:T27 Arg2:T41	
R73	Overlap Arg1:T27 Arg2:T47	
R74	Before Arg1:T27 Arg2:T26	
T86	Quantifier_or_Qualifier 2003 2013	alto grado
R75	Has_Quantifier_or_Qualifier Arg1:T28 Arg2:T86	
R78	Overlap Arg1:T65 Arg2:T36	
R79	Overlap Arg1:T65 Arg2:T37	
T87	PROC 1792 1803	inscribirse
#74	AnnotatorNotes T87	C4041024; Enrollment in clinical trial; Research Activity
R80	Before Arg1:T87 Arg2:T30	
R83	Experiences Arg1:T54 Arg2:T12	
R49	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T80	
R76	Experiences Arg1:T58 Arg2:T60	
#75	AnnotatorNotes T86	C5547531; High histologic grade; Classification
#76	AnnotatorNotes T46	C0521116; Current (present time); Temporal Concept
A18	Experiencer T33 Patient
A19	Experiencer T35 Patient
A20	Experiencer T50 Patient
A21	Experiencer T51 Patient
A22	Experiencer T52 Patient
A23	Experiencer T53 Patient
A24	Experiencer T54 Patient
A25	Experiencer T38 Other
A26	Experiencer T55 Patient
A27	Experiencer T56 Patient
A28	Experiencer T39 Other
A29	Experiencer T40 Patient
A30	Experiencer T57 Patient
A31	Experiencer T43 Other
A32	Experiencer T44 Patient
A33	Experiencer T45 Patient
A34	Experiencer T49 Other
A35	Experiencer T58 Patient
